Advanced search
Publication Cover
Postgraduate Medicine Volume 128, 2016 - Issue 2
Submit an article Journal homepage
233
Views
6
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

Characterization of the Percutaneous Absorption of Ketoprofen Using the Franz Skin Finite Dose Model

August S. BassaniResearch and Development, Professional Compounding Centers of America (PCCA), Houston, TC, USA
,
Daniel BanovResearch and Development, Professional Compounding Centers of America (PCCA), Houston, TC, USA
&
Ha PhanResearch and Development, Professional Compounding Centers of America (PCCA), Houston, TC, USACorrespondence[email protected]
Pages 262-267 | Received 09 Oct 2015, Accepted 18 Jan 2016, Published online: 07 Feb 2016

References

  • Cimmino MA, Ferrone C, Cutolo M. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2011;25:174.
  • Uhl RL, Roberts TT, Papaliodis DN, et al. Management of chronic musculoskeletal pain. J Am Acad Orthop Surg. 2014;22:101–110.
  • Bergman S. Management of musculoskeletal pain. Best Pract Res Clin Rheumatol. 2006;21:155–156.
  • Williams KD. Managing pain with transdermal ketoprofen. Int J Pharm Compd. 2010;14:204–206.
  • Schnitzer TJ. Update on guidelines for the treatment of chronic musculoskeletal pain. Clin Rheumatol. 2006;25(Suppl 1):22–29.
  • Ketoprofen. Clinical Pharmacology. 2014. [ cited 2015 Apr 9]. Available from: www.clinicalpharmacology.com
  • Williams AS, Goodfellow R. Pharmacology in the musculoskeletal system. Nurse Prescribing. 2013;11:499–504.
  • Beetge E, Du Plessis J, Muller DG, et al. The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAID’s on their transdermal absorption. Int J Pharm. 2000;193:261–264.
  • Alexander K, Wynn T. Transdermal gel in the treatment of postoperative pain. Int J Pharm Compd. 2007;11:181.
  • Allen L. Transdermals: the skin as part of a drug delivery system. Int J Pharm Compd. 2011;15:308–314.
  • Newton SJ, Cook JM. Considerations for percutaneous absorption. Int J Pharm Compd. 2010;14:301–304.
  • U.S. Pharmacopeial Convention. Pharmaceutical compounding—nonsterile preparations. In: U.S.P. Convention, editor. US: U.S. Pharmacopeial Convention; 2014. p. 795. [cited 2015 May 6]. Accessed from: http://www.usp.org/sites/default/files/usp_pdf/EN/gc795.pdf
  • Belgamwar V, Pandey M, Chauk D, et al. Pluronic lecithin organogel. Asian J Pharm. 2008;2:134.
  • Cannavino CR, Abrams J, Palinkas LA, et al. Efficacy of transdermal ketoprofen for delayed onset muscle soreness. Clin J Sport Med. 2003;13:200–208.
  • Bassani A, Banov D, Lehman P. Evaluation of the percutaneous absorption of promethazine hydrochloride, in vitro, using the human ex vivo skin model. Int J Pharm Compd. 2008;12:270–273.
  • Franz TJ, Lehman PA, Raney SG. Use of excised human skin to assess the bioequivalence of topical products. Skin Pharmacol Physiol. 2009;22:276–286.
  • Baert B, Boonen J, Burvenich C, et al. A new discriminative criterion for the development of Franz diffusion tests for transdermal pharmaceuticals. J Pharm Pharm Sci. 2010;13(2):218–230.
  • Franz TJ, Lehman PA. The use of water permeability as a means of validation of skin integrity in in vitro percutaneous absorption studies. J Invest Dermatol. 1990;94:525.
  • United States Nuclear Regulatory Commission. Backgrounder on tritium, radiation protection limits, and drinking water standards. Washington (DC): United States Nuclear Regulatory Commission; 2015. [ cited 2015 Apr 9]. Available from: http://www.nrc.gov/reading-rm/doc-collections/fact-sheets/tritium-radiation-fs.html
  • Collins GB. Liquid scintillation counting. J Am Chem Soc. 1959;81:4122–4123.
  • Cárdenas ZJ, Jiménez DM, Martínez F. Preferential solvation of ketoprofen in some co-solvent binary mixtures. J Solut Chem. 2014;43:1904–1915.
  • Brown S, Erickson B, Muller G, et al. Compounded analgesic therapy for disorders of movement: arthritis, neuropathic pain, and postpolio syndrome. Int J Pharm Compd. 2010;14:182–192.
  • Marshall R, Vidaurri VA, Boomsma D, et al. Case reports: compounding to relieve arthritis pain. Int J Pharm Compd. 2008;12:498–504.
  • Bramwell BL, Williams LA. The use of pluronic lecithin organogels in the transdermal delivery of drugs. Int J Pharm Compd. 2012;16(1):62–63.
  • Akhtar N. Vesicles: a recently developed novel carrier for enhanced topical drug delivery. Curr Drug Deliv. 2014;11(1):87–97.
  • Dhamecha DL, Rtahi AA, Saifee M, et al. Drug vehicle based approaches of penetration enhancement. Int J Pharm Pharm Sci. 2009;1:24–46.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.